Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 15 | 2020 | 89 | 5.130 |
Why?
|
| Electronic Nicotine Delivery Systems | 9 | 2021 | 36 | 3.690 |
Why?
|
| Nicotinic Agonists | 6 | 2020 | 27 | 2.060 |
Why?
|
| Receptors, Nicotinic | 5 | 2020 | 5 | 1.820 |
Why?
|
| Vaping | 4 | 2020 | 16 | 1.790 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 7 | 1.400 |
Why?
|
| Animals | 27 | 2021 | 1238 | 1.390 |
Why?
|
| Respiratory Center | 7 | 2020 | 7 | 1.210 |
Why?
|
| Aerosols | 3 | 2019 | 8 | 1.000 |
Why?
|
| Respiration | 3 | 2019 | 4 | 0.870 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2021 | 179 | 0.830 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 2 | 0.760 |
Why?
|
| Seizures | 1 | 2020 | 5 | 0.760 |
Why?
|
| Tobacco Products | 1 | 2019 | 3 | 0.740 |
Why?
|
| Drug Delivery Systems | 3 | 2018 | 7 | 0.720 |
Why?
|
| Behavior, Animal | 1 | 2019 | 24 | 0.710 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 11 | 0.680 |
Why?
|
| Rats | 13 | 2020 | 432 | 0.680 |
Why?
|
| Male | 15 | 2020 | 1649 | 0.670 |
Why?
|
| Uterus | 1 | 2017 | 12 | 0.640 |
Why?
|
| Cigarette Smoking | 1 | 2017 | 10 | 0.640 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2021 | 60 | 0.570 |
Why?
|
| Cotinine | 4 | 2020 | 22 | 0.570 |
Why?
|
| Smoking | 4 | 2020 | 49 | 0.540 |
Why?
|
| Patch-Clamp Techniques | 4 | 2013 | 5 | 0.520 |
Why?
|
| Neurons | 4 | 2012 | 41 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 185 | 0.480 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 3 | 0.470 |
Why?
|
| Mice | 9 | 2020 | 508 | 0.460 |
Why?
|
| Respiratory Mechanics | 2 | 2003 | 3 | 0.460 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 143 | 0.450 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2020 | 23 | 0.450 |
Why?
|
| Autophagy | 3 | 2021 | 10 | 0.450 |
Why?
|
| Heart | 3 | 2020 | 15 | 0.430 |
Why?
|
| Pregnancy | 7 | 2021 | 305 | 0.420 |
Why?
|
| Medulla Oblongata | 2 | 2020 | 2 | 0.420 |
Why?
|
| Receptors, GABA-A | 3 | 2017 | 4 | 0.410 |
Why?
|
| Protein Subunits | 3 | 2017 | 6 | 0.400 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 54 | 0.370 |
Why?
|
| Flavonols | 3 | 2014 | 3 | 0.360 |
Why?
|
| Humans | 8 | 2020 | 2493 | 0.350 |
Why?
|
| Female | 8 | 2021 | 1733 | 0.340 |
Why?
|
| Neurochemistry | 1 | 2006 | 1 | 0.300 |
Why?
|
| Central Nervous System | 1 | 2006 | 4 | 0.300 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 3 | 0.300 |
Why?
|
| Biological Assay | 1 | 2006 | 3 | 0.300 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 14 | 0.300 |
Why?
|
| Nicotinic Antagonists | 3 | 2017 | 3 | 0.300 |
Why?
|
| Electrodes | 1 | 2006 | 2 | 0.300 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 3 | 0.280 |
Why?
|
| Ethanol | 2 | 2017 | 52 | 0.270 |
Why?
|
| DNA Methylation | 2 | 2021 | 13 | 0.260 |
Why?
|
| Maternal Exposure | 2 | 2021 | 8 | 0.250 |
Why?
|
| Myocardium | 2 | 2020 | 15 | 0.240 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 26 | 0.240 |
Why?
|
| Inhalation | 1 | 2003 | 1 | 0.230 |
Why?
|
| Receptors, AMPA | 1 | 2003 | 2 | 0.230 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 3 | 0.230 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 12 | 0.230 |
Why?
|
| Oxidative Stress | 5 | 2020 | 102 | 0.220 |
Why?
|
| Mice, Knockout | 2 | 2019 | 112 | 0.220 |
Why?
|
| Membrane Potentials | 4 | 2013 | 11 | 0.210 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 2 | 0.210 |
Why?
|
| Biological Clocks | 2 | 2019 | 4 | 0.210 |
Why?
|
| Animals, Newborn | 4 | 2021 | 54 | 0.200 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 26 | 0.200 |
Why?
|
| Brain | 1 | 2021 | 55 | 0.200 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 2 | 0.200 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2008 | 4 | 0.200 |
Why?
|
| Mice, Obese | 1 | 2020 | 23 | 0.190 |
Why?
|
| Buffers | 1 | 2020 | 2 | 0.190 |
Why?
|
| Amygdala | 1 | 2020 | 1 | 0.190 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2020 | 1 | 0.190 |
Why?
|
| Adenine | 1 | 2020 | 1 | 0.190 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2020 | 7 | 0.190 |
Why?
|
| Hippocampus | 2 | 2017 | 13 | 0.190 |
Why?
|
| MicroRNAs | 1 | 2020 | 41 | 0.190 |
Why?
|
| Ammonia | 1 | 2019 | 1 | 0.190 |
Why?
|
| Ion Transport | 1 | 2019 | 1 | 0.190 |
Why?
|
| Anion Transport Proteins | 1 | 2019 | 1 | 0.190 |
Why?
|
| Antiporters | 1 | 2019 | 3 | 0.190 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 14 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 18 | 0.180 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 35 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 7 | 0.180 |
Why?
|
| Stroke Volume | 1 | 2019 | 9 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2019 | 14 | 0.180 |
Why?
|
| Diet, Western | 1 | 2019 | 7 | 0.180 |
Why?
|
| Apoptosis | 1 | 2020 | 162 | 0.170 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2018 | 1 | 0.170 |
Why?
|
| Models, Animal | 1 | 2018 | 16 | 0.170 |
Why?
|
| Fatty Liver | 1 | 2019 | 53 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 48 | 0.170 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 8 | 0.160 |
Why?
|
| Mecamylamine | 1 | 2017 | 7 | 0.160 |
Why?
|
| Ovary | 1 | 2017 | 12 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 37 | 0.160 |
Why?
|
| Anxiety | 2 | 2014 | 20 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2017 | 71 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2021 | 180 | 0.130 |
Why?
|
| Memory Disorders | 1 | 2014 | 2 | 0.130 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 1 | 0.130 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2014 | 1 | 0.130 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2014 | 1 | 0.130 |
Why?
|
| Synaptic Potentials | 1 | 2014 | 2 | 0.130 |
Why?
|
| Nucleus Accumbens | 1 | 2014 | 8 | 0.130 |
Why?
|
| Alcoholism | 1 | 2014 | 15 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 14 | 0.120 |
Why?
|
| Synaptic Transmission | 2 | 2019 | 2 | 0.120 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2013 | 1 | 0.120 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 1 | 0.120 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2013 | 1 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2013 | 6 | 0.120 |
Why?
|
| Lethal Dose 50 | 1 | 2012 | 1 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2012 | 3 | 0.120 |
Why?
|
| Equipment Design | 1 | 2012 | 9 | 0.110 |
Why?
|
| Electrophysiology | 1 | 2012 | 4 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 118 | 0.110 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2012 | 1 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 6 | 0.110 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 10 | 0.110 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 1 | 0.110 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2012 | 1 | 0.110 |
Why?
|
| Alcoholic Intoxication | 1 | 2012 | 2 | 0.110 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 4 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 93 | 0.100 |
Why?
|
| Bicarbonates | 3 | 2019 | 3 | 0.100 |
Why?
|
| HEK293 Cells | 3 | 2019 | 8 | 0.100 |
Why?
|
| Periodicity | 2 | 2008 | 6 | 0.100 |
Why?
|
| CpG Islands | 2 | 2021 | 3 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 25 | 0.100 |
Why?
|
| Inhalation Exposure | 2 | 2021 | 8 | 0.100 |
Why?
|
| Echocardiography | 2 | 2020 | 9 | 0.100 |
Why?
|
| Reactive Oxygen Species | 2 | 2020 | 36 | 0.090 |
Why?
|
| Sudden Infant Death | 1 | 2009 | 1 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2009 | 2 | 0.090 |
Why?
|
| Glutamic Acid | 1 | 2009 | 2 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2009 | 49 | 0.090 |
Why?
|
| Apnea | 1 | 2008 | 1 | 0.080 |
Why?
|
| Receptors, Neuropeptide | 1 | 2008 | 1 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 3 | 0.080 |
Why?
|
| Somatostatin | 1 | 2008 | 10 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 9 | 0.080 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2008 | 1 | 0.080 |
Why?
|
| Xenopus laevis | 1 | 2008 | 4 | 0.080 |
Why?
|
| Oocytes | 1 | 2008 | 5 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 37 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2008 | 18 | 0.080 |
Why?
|
| Phenotype | 2 | 2020 | 40 | 0.080 |
Why?
|
| Sodium | 2 | 2019 | 28 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2006 | 1 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2006 | 1 | 0.080 |
Why?
|
| Neurophysiology | 1 | 2006 | 1 | 0.080 |
Why?
|
| Syringes | 1 | 2006 | 1 | 0.080 |
Why?
|
| Brain Stem | 1 | 2006 | 2 | 0.080 |
Why?
|
| Action Potentials | 1 | 2006 | 2 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2006 | 14 | 0.080 |
Why?
|
| Agar | 1 | 2006 | 1 | 0.070 |
Why?
|
| Diffusion | 1 | 2006 | 1 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2006 | 1 | 0.070 |
Why?
|
| Electric Capacitance | 1 | 2006 | 1 | 0.070 |
Why?
|
| Nanotechnology | 1 | 2006 | 1 | 0.070 |
Why?
|
| Potassium Chloride | 1 | 2006 | 4 | 0.070 |
Why?
|
| Chlorides | 1 | 2006 | 5 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 6 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2006 | 16 | 0.070 |
Why?
|
| Algorithms | 1 | 2006 | 33 | 0.070 |
Why?
|
| Calcium Channels | 1 | 2006 | 6 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2006 | 5 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 12 | 0.070 |
Why?
|
| Calcium | 1 | 2006 | 35 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2006 | 42 | 0.070 |
Why?
|
| Biomarkers | 2 | 2020 | 58 | 0.070 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2003 | 1 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2003 | 3 | 0.060 |
Why?
|
| Age Factors | 2 | 2014 | 90 | 0.060 |
Why?
|
| Hypoglossal Nerve | 1 | 2002 | 1 | 0.060 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2021 | 1 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 1 | 0.050 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 11 | 0.050 |
Why?
|
| Gestational Age | 1 | 2021 | 29 | 0.050 |
Why?
|
| Transfection | 2 | 2013 | 46 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 3 | 0.050 |
Why?
|
| Smad Proteins | 1 | 2020 | 10 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 11 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 9 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2020 | 12 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 31 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 22 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 21 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 9 | 0.050 |
Why?
|
| Fetal Development | 1 | 2020 | 21 | 0.050 |
Why?
|
| Precision Medicine | 1 | 2020 | 1 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 7 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 7 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2019 | 2 | 0.050 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2019 | 5 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 9 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 81 | 0.050 |
Why?
|
| Receptors, Opioid, mu | 1 | 2019 | 14 | 0.050 |
Why?
|
| Cell Line | 1 | 2019 | 80 | 0.050 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 6 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 10 | 0.040 |
Why?
|
| Mutation | 1 | 2019 | 28 | 0.040 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 17 | 0.040 |
Why?
|
| Transcriptome | 1 | 2019 | 18 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 12 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 15 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 17 | 0.040 |
Why?
|
| Risk Factors | 1 | 2020 | 240 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 39 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2019 | 116 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 133 | 0.040 |
Why?
|
| GABAergic Neurons | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2014 | 10 | 0.030 |
Why?
|
| Carbonates | 1 | 2013 | 1 | 0.030 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2013 | 1 | 0.030 |
Why?
|
| Mesylates | 1 | 2013 | 1 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 3 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 7 | 0.030 |
Why?
|
| Ethylmaleimide | 1 | 2013 | 6 | 0.030 |
Why?
|
| Nitrates | 1 | 2013 | 6 | 0.030 |
Why?
|
| Gramicidin | 1 | 2012 | 1 | 0.030 |
Why?
|
| Equipment Reuse | 1 | 2012 | 1 | 0.030 |
Why?
|
| CHO Cells | 1 | 2012 | 6 | 0.030 |
Why?
|
| Cricetinae | 1 | 2012 | 11 | 0.030 |
Why?
|
| Cost Savings | 1 | 2012 | 6 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 18 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2012 | 2 | 0.030 |
Why?
|
| Dogs | 1 | 2012 | 5 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 7 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 45 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 62 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2012 | 8 | 0.030 |
Why?
|
| Nerve Net | 1 | 2008 | 1 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2008 | 1 | 0.020 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2008 | 1 | 0.020 |
Why?
|
| Wakefulness | 1 | 2008 | 1 | 0.020 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Drosophila | 1 | 2008 | 4 | 0.020 |
Why?
|
| Dependovirus | 1 | 2008 | 6 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 16 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2008 | 3 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 2006 | 1 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 2 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 4 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2006 | 10 | 0.020 |
Why?
|
| Spleen | 1 | 2006 | 10 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 18 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 29 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2006 | 31 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 52 | 0.020 |
Why?
|